课题基金 / 基金详情

Nicotinic acetylcholine receptor function in the mesolimbic dopamine system

Nicotinic acetylcholine receptor function in the mesolimbic dopamine system
中脑边缘多巴胺系统中烟碱乙酰胆碱受体的功能
批准号:
10631915
负责人:
Ryan Michael Drenan
金额:
$37.89万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
未结题
起止时间:
2014-08-01 至 2025-05-31
关键词:
AcetylcholineAcuteAddressAffectAlkaloidsAnimal BehaviorAnimalsAreaArousalAttentionAwardAxonBehaviorBehavioralBenchmarkingBiologicalBrainCell CommunicationCell NucleusCellsCessation of lifeChronicCommunicationComplementComplexCoupledDataDendritesDevelopmentDopamineEffectivenessElectrophysiology (science)FiberFosteringFundingGene Expression ProfilingGeneticGleanGlutamatesGoalsHealthHeterogeneityHypertensionImageIndividualKnowledgeLocationMalignant neoplasm of lungMapsMeasuresMediatingMethodsMidbrain structureMolecularMoodsMuscarinic Acetylcholine ReceptorNeurodevelopmental DisorderNeuronsNeurosciencesNeurotransmittersNicotineNicotine DependenceNicotine WithdrawalNicotinic ReceptorsOutputParkinson DiseasePathway interactionsPatternPharmacotherapyPhotometryPopulationProcessProsencephalonPublicationsPulmonary EmphysemaQualifyingRelapseReportingResearchResearch PersonnelResolutionRewardsSchizophreniaSignal TransductionSiteSliceSolidSynapsesSynaptic TransmissionSystemTechniquesTobacco smokeUnited StatesVentral Tegmental AreaWorkaddictionawakecell typecholinergiccognitive functionconditioned place preferencedesensitizationdopaminergic neuronexperimental studygamma-Aminobutyric AcidinnovationinsightmRNA Expressionmesolimbic systemmotivated behaviormotor learningnervous system disorderneurochemistryneuroregulationneurotransmissionnicotine exposurenicotine rewardnovelnovel therapeutic interventionoptogeneticspresynapticreceptorreceptor functionresponsesmoking cessationtobacco productstooltransmission processtwo photon microscopytwo-photonvesicular glutamate transporter 2

项目摘要

项目成果

Ryan Michael Drenan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Chronic exposure to nicotine in tobacco products results in numerous health consequences (lung cancer, emphysema, hypertension, etc.) and accounts for over 6 million deaths per year. Relapse rates are high among those who attempt to quit smoking, and pharmacotherapies that seek to foster smoking cessation have moderate effectiveness. Thus, there is a significant unmet need for more effective strategies to treat nicotine dependence. Development of such strategies requires a more detailed understanding of the biological mechanisms leading to nicotine addiction. An essential goal related to mechanistic studies on nAChRs is gaining a better understanding of the location and activity of nAChRs in discrete sites within individual nerve cells. It is also critical that we connect this location/activity information to the various neurochemically-defined (e.g. dopamine, GABA, glutamate) cell types within the brain reward pathways. For these specific cell types in the reward pathway, recent research points to a highly complex input/output relationship. We identified nAChR expression in glutamate-producing neurons in the ventral tegmental area (VTA), and have demonstrated that these receptors enable nicotine- or ACh-mediated alterations in synaptic transmission within the VTA. However, several gaps in knowledge remain, which we will address in this project. First (in Aim 1), we will identify the location within VTA glutamate neurons where nAChRs show the greatest functional activity. This will be done using electrophysiological recordings during 2-photon imaging of neurons in brain slices. This approach will be coupled with studies using a novel photoactivatable nicotine, which we recently introduced. Directly connecting this structural and functional information is critical to fully understanding how nAChRs modulate glutamate transmission in the VTA. In Aim 2, we will answer questions related to nAChR modulation of cell-cell communication within the VTA. Glutamate neurons in this nucleus directly impinge on local DA/GABA neurons, activity which is modulated by nAChR activity on glutamate cells. We will investigate the mechanisms underlying this synaptic communication using optogenetics, photostimulation techniques, and 2-photon microscopy. In Aim 3, we move our queries to the behaving animal to determine which of the components investigated in Aims 1-2 are most important during animal behavior. Using fiber photometry, we will image Ca2+ activity in VTA neurons during acute nicotine exposure and during acquisition/expression of nicotine conditioned reward behavior. To complement these experiments, we will also use chemogenetics to determine whether VTA glutamate neurons are important for nicotine reward-like behavior. By determining how cholinergic mechanisms map onto the complexity (neurochemical and connectivity) of cell types in the VTA, this project will significantly advance our understanding of cholinergic neurotransmission. These studies could also lead to novel treatments for addiction or novel hypotheses about reward system function/activity.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Probing Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices via Laser Flash Photolysis of Photoactivatable Nicotine.
通过光激活尼古丁的激光闪光光解探测小鼠脑切片中的烟碱乙酰胆碱受体功能。
DOI: 10.3791/58873
发表时间: 2019
期刊: Journal of visualized experiments : JoVE
影响因子: --
作者: [Arvin,MatthewC, Wokosin,DavidL, Banala,Sambashiva, Lavis,LukeD, Drenan,RyanM]
通讯作者: Drenan,RyanM
DOI: 10.1371/journal.pone.0188715
发表时间: 2017
期刊: PloS one
影响因子: 3.7
作者: [Parker RL, O'Neill HC, Henley BM, Wageman CR, Drenan RM, Marks MJ, Miwa JM, Grady SR, Lester HA]
通讯作者: Lester HA
Differential Nicotinic Modulation of Glutamatergic and GABAergic VTA Microcircuits.
谷氨酸能和 GABA 能 VTA 微电路的微分烟碱调节。
DOI: 10.1523/eneuro.0298-19.2019
发表时间: 2019
期刊: eNeuro
影响因子: 3.4
作者: [Yan,Yijin, Beckley,NicoleA, Kim,VeronicaJ, Drenan,RyanM]
通讯作者: Drenan,RyanM
Cholinergic mechanisms of cocaine reinforcement probed with nicotinic receptor gene editing
Cholinergic mechanisms of cocaine reinforcement probed with nicotinic receptor gene editing
Identifying nicotine withdrawal mechanisms hidden within habenular complexity
Photoactivatable ligands for nicotinic optopharmacology
海外基金